Skip to main content

Table 2 Summary of experts' choices and their additional suggestions if not in concordance with A, B or C

From: UKCTOCS update: applying insights of delayed effects in cancer screening trials to the long-term follow-up mortality analysis

Expert Expertise Choice Additional suggestions
EX1 Biostatistics, public health A Suggests only include cancers diagnosed from period of intervention.
EX2 Biostatistics, clinical trials and cancer research A  
EX3 Statistics A Ticked “alternative” but suggested hybrid of A for testing and C for estimation—interpreted as A
EX4 Cancer epidemiology, prevention and screening Change analysis Suggested “number needed to screen”.
EX5 Biostatistics, cancer epidemiology Change analysis Did not complete form but indicated choice by email, test based on difference of restricted mean survival time (RMST).
EX6 Biostatistics and epidemiology Change analysis Suggested splitting data into yearly bins and assess HR in each, possibly with smoothing. Avoid single HR.
EX7 Biostatistics, clinical trials and cancer research C Did not complete form but indicated choice by email. Prefers more parsimonious model with interpretable parameters.
EX8 Biostatistics, clinical trials C  
EX9 Biostatistics, public health C Prefers more parsimonious model with interpretable parameters.
EX10 Cancer epidemiology, public health C Also suggests “versatile weighted log-rank test”
EX11 Statistics, public policy C  
EX12 Biostatistics Did not respond within timeframe